New dialysis approach aims to reduce bleeding risks in kidney patients with liver failure
NCT ID NCT07579663
First seen May 14, 2026 · Last updated May 14, 2026
Summary
This study compares a new, personalized way of giving blood-thinning medication during kidney dialysis to the standard method. It involves 142 adults with acute kidney injury or advanced chronic kidney disease who also have liver failure or poor blood flow. The goal is to see if the personalized approach reduces complications and keeps the dialysis filter working longer.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AKI - ACUTE KIDNEY INJURY are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.